- Home
- BEDU vs CRVO Comparison
BEDU vs CRVO Comparison
Compare BEDU & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- CRVO
- Stock Information
- Founded
- BEDU 1994
- CRVO 2001
- Country
- BEDU United Kingdom
- CRVO United States
- Employees
- BEDU N/A
- CRVO N/A
- Industry
- BEDU Other Consumer Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- CRVO Health Care
- Exchange
- BEDU Nasdaq
- CRVO Nasdaq
- Market Cap
- BEDU 63.8M
- CRVO 71.1M
- IPO Year
- BEDU 2017
- CRVO N/A
- Fundamental
- Price
- BEDU $2.14
- CRVO $8.25
- Analyst Decision
- BEDU
- CRVO Strong Buy
- Analyst Count
- BEDU 0
- CRVO 6
- Target Price
- BEDU N/A
- CRVO $21.50
- AVG Volume (30 Days)
- BEDU 6.5K
- CRVO 72.4K
- Earning Date
- BEDU 11-25-2025
- CRVO 11-10-2025
- Dividend Yield
- BEDU N/A
- CRVO N/A
- EPS Growth
- BEDU N/A
- CRVO N/A
- EPS
- BEDU N/A
- CRVO N/A
- Revenue
- BEDU $224,321,752.00
- CRVO $6,159,786.00
- Revenue This Year
- BEDU N/A
- CRVO N/A
- Revenue Next Year
- BEDU N/A
- CRVO N/A
- P/E Ratio
- BEDU N/A
- CRVO N/A
- Revenue Growth
- BEDU N/A
- CRVO N/A
- 52 Week Low
- BEDU $1.35
- CRVO $1.80
- 52 Week High
- BEDU $2.24
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- BEDU 55.95
- CRVO 61.86
- Support Level
- BEDU $2.14
- CRVO $7.11
- Resistance Level
- BEDU $2.18
- CRVO $8.62
- Average True Range (ATR)
- BEDU 0.02
- CRVO 0.53
- MACD
- BEDU -0.01
- CRVO 0.18
- Stochastic Oscillator
- BEDU 37.74
- CRVO 80.78
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom and the United States. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.